Alpine Global Management, LLC Longeveron Inc. Transaction History

Alpine Global Management, LLC

  • $449 Million
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 06, 2024
BUY
$2.52 - $4.0 $189,000 - $300,000
75,000 New
75,000 $253,000
Q2 2023

Nov 21, 2023
BUY
$2.52 - $4.0 $189,000 - $300,000
75,000 New
75,000 $253,000
Q2 2023

Aug 14, 2023
BUY
$2.52 - $4.0 $189,000 - $300,000
75,000 New
75,000 $253,000
Q1 2022

May 13, 2022
SELL
$5.06 - $13.8 $53,555 - $146,059
-10,584 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.92 - $42.3 $30,905 - $447,703
10,584 New
10,584 $128,000

Others Institutions Holding LGVN

# of Institutions
2
Shares Held
581
Call Options Held
0
Put Options Held
0
View Full List

About Longeveron Inc.

LGVN Quotes by TradingView
  • Ticker LGVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,925,940
  • Market Cap $12.4M
  • Description
  • Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...
More about LGVN
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email